Zobrazuji výsledky 1 - 20 z 30 pro vyhledávání 'Gee‐Chen Chang', doba hledání: 0,07 s.
Upřesnit hledání
-
1
A novel tool to evaluate and quantify radiation pneumonitis: A retrospective analysis of correlation of dosimetric parameters with volume of pneumonia patch Autor Jing-Wen Huang, Jing-Wen Huang, Yi-Hui Lin, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Jeremy J. W. Chen
Vydáno 2023-03-01
Článek -
2
An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan Autor Shang-Gin Wu, Shang-Gin Wu, Chi-Lu Chiang, Chi-Lu Chiang, Chi-Lu Chiang, Chien-Ying Liu, Chin-Chou Wang, Po-Lan Su, Te-Chun Hsia, Jin-Yuan Shih, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang
Vydáno 2020-09-01
Článek -
3
-
4
-
5
-
6
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma Autor Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Chun-Ju Chiang, Chun-Ju Chiang, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Zhe-Rong Zheng, Zhe-Rong Zheng, Zhe-Rong Zheng, Kun-Chieh Chen, Kun-Chieh Chen, Cheng-Hsiang Chu, Cheng-Hsiang Chu, Yen-Hsiang Huang, Yen-Hsiang Huang, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Wen-Chung Lee, Wen-Chung Lee, Tsung-Ying Yang, Tsung-Ying Yang, Tsang-Wu Liu, Jiun-Yi Hsia, Jiun-Yi Hsia, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang
Vydáno 2023-02-01
Článek -
7
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma Autor Zhe-Rong Zheng, Zhe-Rong Zheng, Zhe-Rong Zheng, Hsiu-Ying Ku, Kun-Chieh Chen, Kun-Chieh Chen, Chun-Ju Chiang, Chun-Ju Chiang, Chih-Liang Wang, Chih-Liang Wang, Chih-Yi Chen, Chih-Yi Chen, Chun-Ming Tsai, Ming-Shyan Huang, Ming-Shyan Huang, Ming-Shyan Huang, Chong-Jen Yu, Chong-Jen Yu, Chong-Jen Yu, Jin-Shing Chen, Jin-Shing Chen, Jin-Shing Chen, Teh-Ying Chou, Teh-Ying Chou, Wen-Chung Lee, Wen-Chung Lee, Chun-Chieh Wang, Tsang-Wu Liu, Jiun-Yi Hsia, Jiun-Yi Hsia, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang
Vydáno 2023-03-01
Článek -
8
-
9
Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced <i>EGFR</i>-Mutant Lung Adenocarcinoma Autor Po-Hsin Lee, Yen-Hsiang Huang, Ho Lin, Kuo-Hsuan Hsu, Kun-Chieh Chen, Jeng-Sen Tseng, Gee-Chen Chang, Tsung-Ying Yang
Vydáno 2022-07-01
Článek -
10
-
11
-
12
-
13
Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer Autor Jin-Yuan Shih, Yung-Hung Luo, Gee-Chen Chang, John Wen-Cheng Chang, Chin-Chou Wang, Tsung-Ying Yang, Wei-Tse Fang, Wen-Yi Shau
Vydáno 2024-08-01
Článek -
14
Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. Autor Jen-Yi Lee, Yee-Ming Lee, Gee-Chen Chang, Sung-Liang Yu, Wan-Yu Hsieh, Jeremy J W Chen, Huei-Wen Chen, Pan-Chyr Yang
Vydáno 2011-01-01
Článek -
15
-
16
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M Autor Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Tsung-Ying Yang, Gee-Chen Chang
Vydáno 2021-08-01
Článek -
17
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients Autor Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Yen-Hsiang Huang, Gee-Chen Chang
Vydáno 2022-06-01
Článek -
18
-
19
Real-world Treatment Patterns in Patients with EGFR Mutation-positive NSCLC Receiving a First-Line, First- or Second-generation EGFR Tyrosine Kinase Inhibitor in South Korea and Ta... Autor Jae Cheol Lee, Jen-Yu Hung, Young-Chul Kim, Gee-Chen Chang, Seung Soo Yoo, Sheng-Hsiung Yang, Keith L Davis, Saurabh P Nagar, Aliki Taylor, Sung Yong Lee, Jin-Yuan Shih
Vydáno 2021-05-01
Článek -
20
Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target. Autor Kuan-Chung Hsiao, Neng-Yao Shih, Hsun-Lang Fang, Tze-Sing Huang, Ching-Chuan Kuo, Pei-Yi Chu, Yi-Mei Hung, Shao-Wen Chou, Yi-Yuan Yang, Gee-Chen Chang, Ko-Jiunn Liu
Vydáno 2013-01-01
Článek